MX9705954A - Formulations and methods for reducing skin irritation. - Google Patents

Formulations and methods for reducing skin irritation.

Info

Publication number
MX9705954A
MX9705954A MX9705954A MX9705954A MX9705954A MX 9705954 A MX9705954 A MX 9705954A MX 9705954 A MX9705954 A MX 9705954A MX 9705954 A MX9705954 A MX 9705954A MX 9705954 A MX9705954 A MX 9705954A
Authority
MX
Mexico
Prior art keywords
methods
skin irritation
formulations
reducing skin
animals
Prior art date
Application number
MX9705954A
Other languages
Spanish (es)
Other versions
MXPA97005954A (en
Inventor
Gary Scott Hahn
David Orel Thueson
Original Assignee
Cosmederm Technologies
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cosmederm Technologies filed Critical Cosmederm Technologies
Publication of MXPA97005954A publication Critical patent/MXPA97005954A/en
Publication of MX9705954A publication Critical patent/MX9705954A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/223Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of alpha-aminoacids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/4172Imidazole-alkanecarboxylic acids, e.g. histidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41Amines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74Biological properties of particular ingredients
    • A61K2800/75Anti-irritant

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Detergent Compositions (AREA)

Abstract

Compositions and formulations containing multiply-protonated organic polyamines (such as amino acids with amine-containing side groups), and methods of using the same, for inhibiting skin irritation in animals.
MX9705954A 1995-02-03 1996-02-02 Formulations and methods for reducing skin irritation. MX9705954A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38426395A 1995-02-03 1995-02-03
US384263 1995-02-03
PCT/US1996/001289 WO1996023490A1 (en) 1995-02-03 1996-02-02 Formulations and methods for reducing skin irritation

Publications (2)

Publication Number Publication Date
MXPA97005954A MXPA97005954A (en) 1998-02-01
MX9705954A true MX9705954A (en) 1998-02-28

Family

ID=23516632

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9705954A MX9705954A (en) 1995-02-03 1996-02-02 Formulations and methods for reducing skin irritation.

Country Status (6)

Country Link
EP (1) EP0806947A4 (en)
JP (1) JPH10513452A (en)
AU (1) AU4861196A (en)
CA (1) CA2212127A1 (en)
MX (1) MX9705954A (en)
WO (1) WO1996023490A1 (en)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5837224A (en) * 1996-01-19 1998-11-17 The Regents Of The University Of Michigan Method of inhibiting photoaging of skin
EP0884046A1 (en) * 1997-05-30 1998-12-16 Sara Lee/DE N.V. Cosmetic composition with photoprotective properties
TWI234467B (en) 1997-06-04 2005-06-21 Univ Michigan Composition for inhibiting photoaging of skin
DE19757826A1 (en) * 1997-12-24 1999-07-01 Beiersdorf Ag Use of chaotropic compounds for protection of skin against UV radiation e.g. during exposure to sunlight, phototherapy and photo-chemotherapy
US6060471A (en) * 1998-01-21 2000-05-09 Styczynski; Peter Reduction of hair growth
US20040067212A1 (en) 1998-03-11 2004-04-08 Kabushiki Kaisha Soken Skin conditioner
IL138732A0 (en) * 1998-04-03 2001-10-31 Univ Manitoba The use of polyamines in the treatment of dermatological symptoms
FR2783423B1 (en) * 1998-09-23 2002-06-14 Oreal ASSET DELIVERY SYSTEM COMPRISING, ON A FILM STRUCTURE, A COMPOSITION BASED ON A SALICYLIC ACID DERIVATIVE, AND USES THEREOF
WO2000062741A2 (en) * 1999-04-19 2000-10-26 The Procter & Gamble Company Skin care compositions containing combination of skin care actives
AU4647200A (en) * 1999-04-19 2000-11-02 Procter & Gamble Company, The Skin care compositions containing combination of skin care actives
US6444647B1 (en) * 1999-04-19 2002-09-03 The Procter & Gamble Company Skin care compositions containing combination of skin care actives
US6492326B1 (en) 1999-04-19 2002-12-10 The Procter & Gamble Company Skin care compositions containing combination of skin care actives
FR2807645B1 (en) * 2000-04-12 2005-06-03 Oreal USE OF INHIBITORS OF ALCOHOL DEHYDROGENASE IN THE COSMETIC TREATMENT OF KERATINIC MATTER
FR2816837A1 (en) * 2000-11-17 2002-05-24 Oreal Use of amino sulfonic acid derivatives in cosmetic compositions to aid desquamation, counteract aging and stimulate epidermal renewal
DE10106852A1 (en) * 2001-02-14 2002-09-05 T Luger Anti-inflammatory compounds
CN100350977C (en) 2001-06-14 2007-11-28 大塚制药株式会社 Medicinal compositions
US7045550B2 (en) 2001-08-07 2006-05-16 Wisconsin Alumni Research Foundation Polyamines and analogs for protecting cells during cancer chemotherapy and radiotherapy
ITMI20020189A1 (en) * 2002-02-01 2003-08-01 Giuliani Spa COMPOSITION FOR PHARMACEUTICAL OR DIETARY USE TO COUNTER HAIR LOSS
US20040161392A1 (en) * 2003-02-19 2004-08-19 L'oreal S.A. Skin peeling composition and method
AU2003211520A1 (en) * 2003-02-19 2004-09-09 Kuniyasu Soda Lfa-1 inhibitors and use thereof
ITMI20031570A1 (en) * 2003-07-31 2005-02-01 Giuliani Spa COMPOSITION FOR DIETARY, PHARMACEUTICAL OR COSMETIC USE
FR2860716B1 (en) * 2003-10-13 2005-12-09 Oreal COSMETIC COMPOSITION COMPRISING A HYDROXYACID, A POLYHOLOSIDE AND AN AMINO-SULFONIC COMPOUND
DE102004028599A1 (en) * 2004-06-12 2005-12-29 Henkel Kgaa Mild bleach with increased lightening power
NO20044818D0 (en) * 2004-11-05 2004-11-05 Bioforsk As Spermine in cosmetic preparations
ITUD20050211A1 (en) 2005-12-13 2007-06-14 Rossana Castellana PRODUCT FOR THE TREATMENT OF THE RELATIVE SKIN PROCEDURE OF PREPARATION
DE102006003926A1 (en) * 2006-01-26 2007-08-02 Henkel Kgaa Brightening and / or coloring with reduced irritation potential
DE102006003924A1 (en) * 2006-01-26 2007-08-02 Henkel Kgaa Brightening and / or coloring with reduced irritation potential
DE102006003927A1 (en) * 2006-01-26 2007-08-02 Henkel Kgaa Use of valine in compositions for dyeing or lightening keratinic fibers, especially human hair
DE102006017901A1 (en) * 2006-04-13 2007-10-25 Henkel Kgaa Brightening and / or coloring with improved skin compatibility
JP2008156330A (en) * 2006-04-26 2008-07-10 Toyobo Co Ltd Activating agent and anti-aging agent
DE102006020789A1 (en) * 2006-05-03 2007-11-08 Henkel Kgaa Brightening and / or coloring agent with imidazoles and aminoalcohols
DE102006035252A1 (en) * 2006-07-26 2008-01-31 Henkel Kgaa Hair Dye with Shea Butter
WO2008051080A1 (en) * 2006-10-25 2008-05-02 Fridtjof Bjerke Skin cream comprising a combination of aloe vera and spermine
WO2008091161A1 (en) * 2007-01-26 2008-07-31 Fridtjof Bjerke Cosmetic composition containing spermine and emu oil
EP2219594A4 (en) * 2007-11-27 2015-01-14 Univ Manitoba Use of transglutaminase inhibitor in skin treatment
KR20170129808A (en) * 2015-03-17 2017-11-27 디에스엠 아이피 어셋츠 비.브이. Production method of diaminobutane
JP5966231B1 (en) * 2015-12-14 2016-08-10 有限会社アント Amino acid-containing facial skin preparation
WO2019232644A1 (en) * 2018-06-08 2019-12-12 Vivier Canada Inc. Sterile topical saline putrescine formulation and uses thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3861868A (en) * 1971-03-30 1975-01-21 Procter & Gamble Dyeing human hair with oxidation dyes and arginine or a protamine protein
US4076799A (en) * 1972-12-27 1978-02-28 Cincinnati Milacron, Inc. Method of inhibiting skin irritation
JPS6025479B2 (en) * 1977-03-31 1985-06-18 三洋化成工業株式会社 Surfactant composition for cosmetics and cleaning agents
JPS54163819A (en) * 1978-06-14 1979-12-26 Meito Sangyo Kk Digestive tract ulcer and injury treating agent
US4507321A (en) * 1982-02-17 1985-03-26 The Research Foundation Of State University Of New York Epithelial cell growth regulating composition containing polyamines and a method of using same
EP0100827B1 (en) * 1982-08-17 1986-09-03 Rosical Limited Pharmaceutical composition containing an aliphatic aminosulphonic acid
US4704234A (en) * 1983-01-17 1987-11-03 American Cyanamid Company Compositions comprising imidazole, pyrazole or derivatives thereof for removing undesirable organic matter from a surface
IT1190348B (en) * 1986-06-16 1988-02-16 Lisapharma Spa TOPICAL VAGINAL USE OF P-ISOBUTYLPHENYLPROPIONATE OF LYSINE IN ANTI-INFLAMMATORY TREATMENT
US5091171B2 (en) * 1986-12-23 1997-07-15 Tristrata Inc Amphoteric compositions and polymeric forms of alpha hydroxyacids and their therapeutic use
US5252322A (en) * 1989-09-22 1993-10-12 The Gillette Company Skin tanning compositions containing imidazoles
AU641529B2 (en) * 1990-07-30 1993-09-23 Bloomfield D.A. Zwitterionic compounds and their N-halo derivatives for use in the treatment of clinical conditions
JP3575084B2 (en) * 1994-11-29 2004-10-06 味の素株式会社 Bactericidal disinfectant composition

Also Published As

Publication number Publication date
CA2212127A1 (en) 1996-08-08
JPH10513452A (en) 1998-12-22
EP0806947A4 (en) 1998-10-14
AU4861196A (en) 1996-08-21
EP0806947A1 (en) 1997-11-19
WO1996023490A1 (en) 1996-08-08

Similar Documents

Publication Publication Date Title
MX9705954A (en) Formulations and methods for reducing skin irritation.
DE69626513D1 (en) Imidazolverbindungen
NO971889D0 (en) Compounds and compositions for delivery of active agents
AU1414899A (en) Surfactant-based antimicrobial compositions and methods for using same
AU693747B2 (en) Imidazo(4,5-c)pyridin-4-amines
MY113488A (en) Compounds with growth hormone releasing properties
MY109880A (en) Substituted biphenylpyridones
AU4718496A (en) Use of aerogels in agriculture
AU5833994A (en) Pharmaceutical and dermocosmetic compositions containing equine colostrum
MX9504332A (en) Amino (thio)ether derivatives.
IL125223A0 (en) Novel substituted imidazole compounds
HK1022624A1 (en) Novel substituted imidazole compounds.
MY109310A (en) Antimicrobial method and formulation employing type ii endoglucosidase and antimicrobial agent
BG101139A (en) Heteroatoms-containing cyclopentanopyridyloxazolidinons
MY131300A (en) Antibacterial agents
MY118828A (en) Substituted amino compounds and their use as substances having an analgesic effect
UA35611C2 (en) Topical composition for inhibiting hair growth in mammals, method for application and topical composition for delivering water-soluble pharmaceutical to skin
DE69311541D1 (en) COSMETIC OR PHARMACEUTICAL COMPOSITIONS FOR TOPICAL USE CONTAINING THE DEACYLATED GLYCEROPHOSPHOLIPIDES
TW326395B (en) Water-based hair treatment composition as heat-safe preparation and method of using same
BG102395A (en) New phenylamidine derivatives, method for their preparation and application as medicamentous forms
ZA96401B (en) Cationic copolymers of vinyl amine and vinyl alcohol for the delivery of oligonucleotides
AU1815899A (en) Method and composition to enhance the efficacy of a vaccine using chemokines
GR1002665B (en) Method for the treatment of plants.
UA39178C2 (en) method for minimization of activated protein C degradation (variants) , a pharmaceutical composition and an aqueous solution of activated protein C
EP0190860A3 (en) 6-chloro-3-methyl-1h-2,3,4,5-tetrahydro-3-benzazepine-n-oxide and medical compositions using it